相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
Youn-Sang Jung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Molecular targeted therapies: Ready for prime time in biliary tract cancer
Angela Lamarca et al.
JOURNAL OF HEPATOLOGY (2020)
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma
Robert Montal et al.
JOURNAL OF HEPATOLOGY (2020)
Ivosidenib in IDH1-mutant, chemotherapy-refractory Croatia& cholangiocarcinoma (ClarlDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
Ghassan K. Abou-Alfa et al.
LANCET ONCOLOGY (2020)
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Ghassan K. Abou-Alfa et al.
LANCET ONCOLOGY (2020)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Efficacy and safety of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E mutated biliary tract cancer (BTC): A cohort of the ROAR basket trial.
Zev A. Wainberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma
Paola Bertuccio et al.
JOURNAL OF HEPATOLOGY (2019)
Anatomical, histomorphological and molecular classification of cholangiocarcinoma
Timothy Kendall et al.
LIVER INTERNATIONAL (2019)
Cholangiocarcinoma: Epidemiology and risk factors
Shahid A. Khan et al.
LIVER INTERNATIONAL (2019)
O-005Treating HER2-mutant advanced biliary tract cancer with neratinib: benefits of HER2-directed targeted therapy in the phase 2 SUMMIT ‘basket’ trial
J Harding et al.
ANNALS OF ONCOLOGY (2019)
HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis
Thomas Albrecht et al.
BMC CANCER (2019)
Cellular Plasticity in Liver Regeneration: Spotlight on Cholangiocytes
Janina E. E. Tirnitz-Parker et al.
HEPATOLOGY (2019)
Wnt-β-catenin signalling in liver development, health and disease
Maria J. Perugorria et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Epidemiology of gallbladder cancer
Prashanth Rawla et al.
CLINICAL AND EXPERIMENTAL HEPATOLOGY (2019)
Cholangiocarcinoma - evolving concepts and therapeutic strategies
Sumera Rizvi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Combination of Kras activation and PTEN deletion contributes to murine hepatopancreatic ductal malignancy
Yun-kai Lin et al.
CANCER LETTERS (2018)
Kras and Tp53 Mutations Cause Cholangiocyte- and Hepatocyte-Derived Cholangiocarcinoma
Margaret A. Hill et al.
CANCER RESEARCH (2018)
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
Katherine A. Hoadley et al.
CELL (2018)
Chronic Liver Injury Induces Conversion of Biliary Epithelial Cells into Hepatocytes
Xing Deng et al.
CELL STEM CELL (2018)
Worldwide Burden of and Trends in Mortality From Gallbladder and Other Biliary Tract Cancers
Lindsey A. Torre et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma
Chirag Nepal et al.
HEPATOLOGY (2018)
cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation
Elizabeth Brunt et al.
HEPATOLOGY (2018)
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma
Milind Javle et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations
Christopher P. Wardell et al.
JOURNAL OF HEPATOLOGY (2018)
Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β
Yan Lan et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model
Mingjie Dong et al.
CELL DEATH & DISEASE (2018)
Necroptosis microenvironment directs lineage commitment in liver cancer
Marco Seehawer et al.
NATURE (2018)
155OEfficacy of TAS-120, an irreversible fibroblast growth factor receptor inhibitor (FGFRi), in patients with cholangiocarcinoma and FGFR pathway alterations previously treated with chemotherapy and other FGFRi’s
B Tran et al.
ANNALS OF ONCOLOGY (2018)
Stem cell fate in cancer growth, progression and therapy resistance
Nikki K. Lytle et al.
NATURE REVIEWS CANCER (2018)
Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity
Agrin Moeini et al.
JOURNAL OF HEPATOLOGY (2017)
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice
Shanshan Zhang et al.
JOURNAL OF HEPATOLOGY (2017)
Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration
Alexander Raven et al.
NATURE (2017)
Biliary epithelial injury-induced regenerative response by IL-33 promotes cholangiocarcinogenesis from peribiliary glands
Hayato Nakagawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
New Horizons for Precision Medicine in Biliary Tract Cancers
Juan W. Valle et al.
CANCER DISCOVERY (2017)
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Apinya Jusakul et al.
CANCER DISCOVERY (2017)
Pathology of intrahepatic cholangiocarcinoma
Sandrine Vijgen et al.
HEPATOBILIARY SURGERY AND NUTRITION (2017)
ARQ 087, an oral pan-fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced intrahepatic cholangiocarcinoma (iCCA) with FGFR2 genetic aberrations.
Vincenzo Mazzaferro et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma
Agrin Moeini et al.
CLINICAL CANCER RESEARCH (2016)
The Hepatic, Biliary, and Pancreatic Network of Stem/Progenitor Cell Niches in Humans: A New Reference Frame for Disease and Regeneration
Giacomo Lanzoni et al.
HEPATOLOGY (2016)
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. W. Valle et al.
ANNALS OF ONCOLOGY (2016)
Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma
Xueru Mu et al.
GASTROENTEROLOGY (2016)
Forty-Year Trends in Cholangiocarcinoma Incidence in the US: Intrahepatic Disease on the Rise
Supriya K. Saha et al.
ONCOLOGIST (2016)
Notch3 drives development and progression of cholangiocarcinoma
Rachel V. Guest et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans
L. Che et al.
ONCOGENESIS (2016)
A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion
Tsuneo Ikenoue et al.
SCIENTIFIC REPORTS (2016)
Profiles of Cancer Stem Cell Subpopulations in Cholangiocarcinomas
Vincenzo Cardinale et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution
Nicholas McGranahan et al.
CANCER CELL (2015)
Impact of Metabolic Heterogeneity on Tumor Growth, Invasion, and Treatment Outcomes
M. Robertson-Tessi et al.
CANCER RESEARCH (2015)
IL-33 Facilitates Oncogene-Induced Cholangiocarcinoma in Mice by an Interleukin-6-Sensitive Mechanism
Daisaku Yamada et al.
HEPATOLOGY (2015)
Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment
Xueru Mu et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: Molecular networks and biological concepts
Chiara Raggi et al.
JOURNAL OF HEPATOLOGY (2015)
Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis
Guido Carpino et al.
JOURNAL OF HEPATOLOGY (2015)
Genomic spectra of biliary tract cancer
Hiromi Nakamura et al.
NATURE GENETICS (2015)
Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity
Akihiro Fujimoto et al.
NATURE COMMUNICATIONS (2015)
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma
Daniela Sia et al.
NATURE COMMUNICATIONS (2015)
Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver
Xiaolei Li et al.
ONCOTARGET (2015)
Emerging Roles of Notch Signaling in Liver Disease
Fabian Geisler et al.
HEPATOLOGY (2015)
Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma
Motoko Sasaki et al.
LIVER INTERNATIONAL (2015)
S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma
A. B. El-Khoueiry et al.
BRITISH JOURNAL OF CANCER (2014)
p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer
Darjus F. Tschaharganeh et al.
CELL (2014)
Hippo Pathway Activity Influences Liver Cell Fate
Dean Yimlamai et al.
CELL (2014)
Stem/Progenitor Cells in Liver Development, Homeostasis, Regeneration, and Reprogramming
Atsushi Miyajima et al.
CELL STEM CELL (2014)
Bipotential Adult Liver Progenitors Are Derived from Chronically Injured Mature Hepatocytes
Branden D. Tarlow et al.
CELL STEM CELL (2014)
Pathological diagnosis of flat epithelial lesions of the biliary tract with emphasis on biliary intraepithelial neoplasia
Yasunori Sato et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Evidence for multipotent endodermal stem/progenitor cell populations in human gallbladder
Guido Carpino et al.
JOURNAL OF HEPATOLOGY (2014)
Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features
Jau-Yu Liau et al.
MODERN PATHOLOGY (2014)
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer
Supriya K. Saha et al.
NATURE (2014)
Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway
Maolan Li et al.
NATURE GENETICS (2014)
Evidence against a Stem Cell Origin of New Hepatocytes in a Common Mouse Model of Chronic Liver Injury
Johanna R. Schaub et al.
CELL REPORTS (2014)
A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe
P. Bertuccio et al.
ANNALS OF ONCOLOGY (2013)
A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas
Steffen Zender et al.
CANCER CELL (2013)
Classification, Diagnosis, and Management of Cholangiocarcinoma
Nataliya Razumilava et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Modeling Pathogenesis of Primary Liver Cancer in Lineage-Specific Mouse Cell Types
Agnes Holczbauer et al.
GASTROENTEROLOGY (2013)
Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
Daniela Sia et al.
GASTROENTEROLOGY (2013)
Robust cellular reprogramming occurs spontaneously during liver regeneration
Kilangsungla Yanger et al.
GENES & DEVELOPMENT (2013)
Identification of Intramural Epithelial Networks Linked to Peribiliary Glands That Express Progenitor Cell Markers and Proliferate After Injury in Mice
Frank DiPaola et al.
HEPATOLOGY (2013)
PTEN loss and KRAS activation cooperate in murine biliary tract malignancies
Victoria Marsh et al.
JOURNAL OF PATHOLOGY (2013)
Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers
Waraporn Chan-on et al.
NATURE GENETICS (2013)
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
Yuchen Jiao et al.
NATURE GENETICS (2013)
Activation of Notch Signaling Is Required for Cholangiocarcinoma Progression and Is Enhanced by Inactivation of p53 In Vivo (Publication with Expression of Concern. See vol. 14, 2019)
Mona El Khatib et al.
PLOS ONE (2013)
KrasG12D and p53 Mutation Cause Primary intrahepatic Cholangiocarcinoma
Michael R. O'Dell et al.
CANCER RESEARCH (2012)
Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways
Cedric Coulouarn et al.
CARCINOGENESIS (2012)
Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
Jesper B. Andersen et al.
GASTROENTEROLOGY (2012)
Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma
Naoki Oishi et al.
HEPATOLOGY (2012)
Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes
Mina Komuta et al.
HEPATOLOGY (2012)
Cholangiocarcinomas can originate from hepatocytes in mice
Biao Fan et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes
Sayaka Sekiya et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Recent advances in cancer stem cell research for cholangiocarcinoma
Toshio Kokuryo et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2012)
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study
Freddie Bray et al.
LANCET ONCOLOGY (2012)
Exome sequencing of liver fluke-associated cholangiocarcinoma
Choon Kiat Ong et al.
NATURE GENETICS (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Intra-tumour heterogeneity: a looking glass for cancer?
Andriy Marusyk et al.
NATURE REVIEWS CANCER (2012)
Risk Factors for Cholangiocarcinoma
Gia L. Tyson et al.
HEPATOLOGY (2011)
The cautionary tale of side effects of chronic Notch1 inhibition
Sandra W. Ryeom
JOURNAL OF CLINICAL INVESTIGATION (2011)
The cancer stem cell: premises, promises and challenges
Hans Clevers
NATURE MEDICINE (2011)
Embryology of the Biliary Tract
Hisami Ando
DIGESTIVE SURGERY (2010)
Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver
Samira Benhamouche et al.
GENES & DEVELOPMENT (2010)
Estrogen-dependent gallbladder carcinogenesis in LXRβ-/- female mice
Chiara Gabbi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver
Li Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Basal epithelial stem cells are efficient targets for prostate cancer initiation
Devon A. Lawson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Identification of a Cell of Origin for Human Prostate Cancer
Andrew S. Goldstein et al.
SCIENCE (2010)
Malignant Astrocytomas Originate from Neural Stem/Progenitor Cells in a Somatic Tumor Suppressor Mouse Models
Sheila Alcantara Llaguno et al.
CANCER CELL (2009)
A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer
Ramesh K. Ramanathan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
Yujin Hoshida et al.
CANCER RESEARCH (2009)
Stem Cells and Liver Regeneration
Andrew W. Duncan et al.
GASTROENTEROLOGY (2009)
EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
Taro Yamashita et al.
GASTROENTEROLOGY (2009)
Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation
Liqin Zhu et al.
NATURE (2009)
Crypt stem cells as the cells-of-origin of intestinal cancer
Nick Barker et al.
NATURE (2009)
Embryology of extra- and intrahepatic bile ducts, the ductal plate
T. Roskams et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2008)
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma
Derek Y. Chiang et al.
CANCER RESEARCH (2008)
Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin
Mina Komuta et al.
HEPATOLOGY (2008)
Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation
Tetsuhiro Chiba et al.
GASTROENTEROLOGY (2007)
Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes
Tan A. Ince et al.
CANCER CELL (2007)
Preferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injection
Jason B. Bell et al.
NATURE PROTOCOLS (2007)
Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment
Alexander R. A. Anderson et al.
CELL (2006)
Liver fluke-associated and sporadic cholangiocarcinoma: an immunohistochemical study of bile duct, peribiliary gland and tumour cell phenotypes
N. R. Hughes et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice
Xiaoling Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
JS Lee et al.
NATURE MEDICINE (2006)
Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998
SD Taylor-Robinson et al.
GUT (2001)
Genetic classification of combined hepatocellular-cholangiocarcinoma
H Fujii et al.
HUMAN PATHOLOGY (2000)
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice
EC Holland et al.
NATURE GENETICS (2000)
分享论文
